NCT02257177View on ClinicalTrials.gov

RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

Inhaled TD139

DPI Galectin-3 inhibitor

DRUG

Placebo

DPI placebo

Trial Locations (5)

EX2 5DW

Royal Devon & Exeter Foundation NHS Trust, Exeter

EH16 4SA

Edinburgh University Hospital, Edinburgh

NE3 3HD

The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle

CF48 4DR

Simbec Research Limited, Merthyr Tydfil

SW3 6NP

Royal Brompton Hospital, London

Sponsors

Lead Sponsor

Galecto Biotech AB
All Listed Sponsors
lead

Galecto Biotech AB

INDUSTRY

NCT02257177 - RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients | Biotech Hunter | Biotech Hunter